SlideShare a Scribd company logo

Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)

Mohand Yaghi
Mohand Yaghi
Mohand YaghiMUDr., PgDip urol., ChM urol., FICS urol. at Ministry of Health Kuwait

A lecture about the effect of diabetes mellitus on the erectile function. Dr. Mohand Yaghi was an invited speaker in Al-Jahra scientific day, Kuwait 2015.

Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)

1 of 40
Download to read offline
Dr. Mohand Yaghi
PgDip urol (MU) ChM urol (RCSEdin.)
 Physiology of erection :
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)
 KUW: of 323 patients with DM 2, 31%
had ED, IIEF-5 used. (The prevalence and
predictors of erectile dysfunction in men with newly diagnosed
with type 2 diabetes mellitus. BJU Int. 2007 Jan;99(1):130-4)
 KSA: 376 pts, DM 2, 81% reported ED.
(Erectile Dysfunction and Other Sexual Activity Dysfunctions
among Saudi Type 2 Diabetic Patients. AlMogbel . Int J Health Sci
(Qassim). 2014 Oct;8(4):347-59)
 Risk factors – age, smoking, glu
control, duration of DM & smoking,
occupation, income, education.
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)
Ad

Recommended

DIABETES INDUCED ERECTILE DYSFUNCTION
DIABETES INDUCED ERECTILE DYSFUNCTIONDIABETES INDUCED ERECTILE DYSFUNCTION
DIABETES INDUCED ERECTILE DYSFUNCTIONKishore Krishn
 
Erectile dysfunction in diabetes
Erectile dysfunction in diabetesErectile dysfunction in diabetes
Erectile dysfunction in diabetesPeninsulaEndocrine
 
Family Physician's Approach to Erectile Dysfunction
Family Physician's Approach to Erectile DysfunctionFamily Physician's Approach to Erectile Dysfunction
Family Physician's Approach to Erectile DysfunctionSiewhong Ho
 
Sexual activity after myocardial infarction
Sexual activity after myocardial infarctionSexual activity after myocardial infarction
Sexual activity after myocardial infarctionTarek Anis
 
Tadalista (Tadalafil Tablets)
Tadalista (Tadalafil Tablets)Tadalista (Tadalafil Tablets)
Tadalista (Tadalafil Tablets)Clearsky Pharmacy
 

More Related Content

What's hot

Dr. Paul Turek: Male Hypogonadism and Testosterone
Dr. Paul Turek: Male Hypogonadism and TestosteroneDr. Paul Turek: Male Hypogonadism and Testosterone
Dr. Paul Turek: Male Hypogonadism and TestosteroneThe Turek Clinics
 
Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015siti hamidah
 
Erectile Dysfunction And Tadalafil
Erectile Dysfunction And TadalafilErectile Dysfunction And Tadalafil
Erectile Dysfunction And TadalafilBALASUBRAMANIAM IYER
 
Premature ejaculation
Premature ejaculation Premature ejaculation
Premature ejaculation Wong Lei
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...Suharti Wairagya
 
Phosphodiesterase 5 inhibitors
Phosphodiesterase 5 inhibitorsPhosphodiesterase 5 inhibitors
Phosphodiesterase 5 inhibitorsSoumya Nath Maiti
 
Incretin based therapy of type 2 diabetes mellitus 1
Incretin based therapy of type 2 diabetes mellitus 1Incretin based therapy of type 2 diabetes mellitus 1
Incretin based therapy of type 2 diabetes mellitus 1Pk Doctors
 
Ueda2015 d erectile dysfunction patients_dr.khaled mohy
Ueda2015 d erectile dysfunction patients_dr.khaled mohyUeda2015 d erectile dysfunction patients_dr.khaled mohy
Ueda2015 d erectile dysfunction patients_dr.khaled mohyueda2015
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunctionfitango
 
Cv safety of gliptins
Cv safety of gliptinsCv safety of gliptins
Cv safety of gliptinsDrNeerajB
 
Recent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusRecent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusShailaBanu3
 

What's hot (20)

Dr. Paul Turek: Male Hypogonadism and Testosterone
Dr. Paul Turek: Male Hypogonadism and TestosteroneDr. Paul Turek: Male Hypogonadism and Testosterone
Dr. Paul Turek: Male Hypogonadism and Testosterone
 
Dr KA Apicon Master Slide Presentation
Dr KA Apicon Master Slide PresentationDr KA Apicon Master Slide Presentation
Dr KA Apicon Master Slide Presentation
 
Premature Ejaculation
Premature EjaculationPremature Ejaculation
Premature Ejaculation
 
Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015
 
Sildenafil citrate
Sildenafil citrateSildenafil citrate
Sildenafil citrate
 
Iatrogenic diabetes
Iatrogenic diabetesIatrogenic diabetes
Iatrogenic diabetes
 
Erectile Dysfunction And Tadalafil
Erectile Dysfunction And TadalafilErectile Dysfunction And Tadalafil
Erectile Dysfunction And Tadalafil
 
Premature ejaculation
Premature ejaculation Premature ejaculation
Premature ejaculation
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
SGLT-2
SGLT-2 SGLT-2
SGLT-2
 
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
 
Phosphodiesterase 5 inhibitors
Phosphodiesterase 5 inhibitorsPhosphodiesterase 5 inhibitors
Phosphodiesterase 5 inhibitors
 
Incretin based therapy of type 2 diabetes mellitus 1
Incretin based therapy of type 2 diabetes mellitus 1Incretin based therapy of type 2 diabetes mellitus 1
Incretin based therapy of type 2 diabetes mellitus 1
 
Ueda2015 d erectile dysfunction patients_dr.khaled mohy
Ueda2015 d erectile dysfunction patients_dr.khaled mohyUeda2015 d erectile dysfunction patients_dr.khaled mohy
Ueda2015 d erectile dysfunction patients_dr.khaled mohy
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunction
 
Cv safety of gliptins
Cv safety of gliptinsCv safety of gliptins
Cv safety of gliptins
 
Recent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusRecent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes Mellitus
 
Type 2 DM ; Metformin Best Partner
Type 2 DM ; Metformin Best PartnerType 2 DM ; Metformin Best Partner
Type 2 DM ; Metformin Best Partner
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
Ryzodeg presentation in ramadan by dr shahjada selim
Ryzodeg presentation in ramadan by dr shahjada selimRyzodeg presentation in ramadan by dr shahjada selim
Ryzodeg presentation in ramadan by dr shahjada selim
 

Viewers also liked

Erectile Dysfunction Symptoms And Treatment
Erectile Dysfunction Symptoms And TreatmentErectile Dysfunction Symptoms And Treatment
Erectile Dysfunction Symptoms And TreatmentManas Das
 
Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]Edmond Wong
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunctionfhammoud
 
Male Sexual Dysfunction
Male Sexual DysfunctionMale Sexual Dysfunction
Male Sexual DysfunctionSebastian
 
Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation Dr. Amit Chougule
 
Erectile Dysfunction Treatment Without Medication or Operation
Erectile Dysfunction Treatment Without Medication or OperationErectile Dysfunction Treatment Without Medication or Operation
Erectile Dysfunction Treatment Without Medication or OperationBetterBlue
 
Couple therapy and treatment of sexual dysfunction
Couple therapy and treatment of sexual dysfunctionCouple therapy and treatment of sexual dysfunction
Couple therapy and treatment of sexual dysfunctionGladys Escalante
 
Metabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunctionMetabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunctionTarek Anis
 
Metabolic Syndrome and Erectile Dysfunction
Metabolic Syndrome and Erectile DysfunctionMetabolic Syndrome and Erectile Dysfunction
Metabolic Syndrome and Erectile DysfunctionIris Thiele Isip-Tan
 
Developing sexuality and sexual health policies in the disability sector
Developing sexuality and sexual health policies in the disability sector Developing sexuality and sexual health policies in the disability sector
Developing sexuality and sexual health policies in the disability sector Werksmans Attorneys
 
Sexuality Training for Teens or Adults with Developmental Disabilities
Sexuality Training for Teens or Adults with Developmental DisabilitiesSexuality Training for Teens or Adults with Developmental Disabilities
Sexuality Training for Teens or Adults with Developmental DisabilitiesAmber Osborn
 
LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...
LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...
LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...PROF. DR. SEMIR AL SAMARRAI
 
Disfunción eréctil
Disfunción eréctilDisfunción eréctil
Disfunción eréctilJulio Fonseca
 
Medicalización de la homosexualidad, jimena pandolfi
Medicalización de la homosexualidad, jimena pandolfiMedicalización de la homosexualidad, jimena pandolfi
Medicalización de la homosexualidad, jimena pandolfiCarlos Muñoz
 

Viewers also liked (17)

Erectile Dysfunction Symptoms And Treatment
Erectile Dysfunction Symptoms And TreatmentErectile Dysfunction Symptoms And Treatment
Erectile Dysfunction Symptoms And Treatment
 
Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]Erectile Dysfunction [Dr. Edmond Wong]
Erectile Dysfunction [Dr. Edmond Wong]
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunction
 
Male Sexual Dysfunction
Male Sexual DysfunctionMale Sexual Dysfunction
Male Sexual Dysfunction
 
Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation
 
Erectile Dysfunction Treatment Without Medication or Operation
Erectile Dysfunction Treatment Without Medication or OperationErectile Dysfunction Treatment Without Medication or Operation
Erectile Dysfunction Treatment Without Medication or Operation
 
Couple therapy and treatment of sexual dysfunction
Couple therapy and treatment of sexual dysfunctionCouple therapy and treatment of sexual dysfunction
Couple therapy and treatment of sexual dysfunction
 
Metabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunctionMetabolic syndrome and erectile dysfunction
Metabolic syndrome and erectile dysfunction
 
Classification and Diagnosis of Sexual Dysfunctions
Classification and Diagnosis of Sexual DysfunctionsClassification and Diagnosis of Sexual Dysfunctions
Classification and Diagnosis of Sexual Dysfunctions
 
Metabolic Syndrome and Erectile Dysfunction
Metabolic Syndrome and Erectile DysfunctionMetabolic Syndrome and Erectile Dysfunction
Metabolic Syndrome and Erectile Dysfunction
 
Developing sexuality and sexual health policies in the disability sector
Developing sexuality and sexual health policies in the disability sector Developing sexuality and sexual health policies in the disability sector
Developing sexuality and sexual health policies in the disability sector
 
Sexuality Training for Teens or Adults with Developmental Disabilities
Sexuality Training for Teens or Adults with Developmental DisabilitiesSexuality Training for Teens or Adults with Developmental Disabilities
Sexuality Training for Teens or Adults with Developmental Disabilities
 
LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...
LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...
LECTURE ON RELATIONSHIP BETWEEN OBESITY, TESTOSTERONE DEFICIENCY AND ERECTILE...
 
Impotence
ImpotenceImpotence
Impotence
 
Disfunción eréctil
Disfunción eréctilDisfunción eréctil
Disfunción eréctil
 
Medicalización de la homosexualidad, jimena pandolfi
Medicalización de la homosexualidad, jimena pandolfiMedicalización de la homosexualidad, jimena pandolfi
Medicalización de la homosexualidad, jimena pandolfi
 
Sexual dysfunctions
Sexual dysfunctionsSexual dysfunctions
Sexual dysfunctions
 

Similar to Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)

GLP1 ANALOGUES- BEYOND DIABETES.pptx
GLP1 ANALOGUES- BEYOND DIABETES.pptxGLP1 ANALOGUES- BEYOND DIABETES.pptx
GLP1 ANALOGUES- BEYOND DIABETES.pptxSayan Chatterjee
 
Pain Management in the Elderly
Pain Management in the ElderlyPain Management in the Elderly
Pain Management in the ElderlyAde Wijaya
 
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...InsideScientific
 
Postprandial hypertriglyceridemia and androgen dysfunction
Postprandial hypertriglyceridemia and androgen dysfunctionPostprandial hypertriglyceridemia and androgen dysfunction
Postprandial hypertriglyceridemia and androgen dysfunctionAlexander Decker
 
Ndei Beta Cell Slide Kit Clinical Implications
Ndei Beta Cell Slide Kit   Clinical ImplicationsNdei Beta Cell Slide Kit   Clinical Implications
Ndei Beta Cell Slide Kit Clinical ImplicationsPPSCME
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile DysfunctionEko indra
 
New treatment trends in alzheimer disease
New treatment trends in alzheimer diseaseNew treatment trends in alzheimer disease
New treatment trends in alzheimer diseaseSarath Menon
 
LHRH agonist vs antagonist in prostate cancer
LHRH agonist vs antagonist in prostate cancerLHRH agonist vs antagonist in prostate cancer
LHRH agonist vs antagonist in prostate cancerAlok Gupta
 
pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...
pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...
pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...GlobalProvidence
 
ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapy
ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapyECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapy
ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapyEuropean School of Oncology
 
Estado actual de terapia sistémica en cáncer renal metastásico
Estado actual de terapia sistémica en cáncer renal metastásicoEstado actual de terapia sistémica en cáncer renal metastásico
Estado actual de terapia sistémica en cáncer renal metastásicoMauricio Lema
 
Treatment Duration Aderence Compliance and Concordance and Management Of Oste...
Treatment Duration Aderence Compliance and Concordance and Management Of Oste...Treatment Duration Aderence Compliance and Concordance and Management Of Oste...
Treatment Duration Aderence Compliance and Concordance and Management Of Oste...National Osteoporosis Society
 
Kiem soat duong huyet tren tien dtd
Kiem soat duong huyet tren tien dtdKiem soat duong huyet tren tien dtd
Kiem soat duong huyet tren tien dtdkhacleson
 
Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...
Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...
Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...lukeman Joseph Ade shittu
 
Evidence based medical management of aub different options
Evidence based medical management of aub different optionsEvidence based medical management of aub different options
Evidence based medical management of aub different optionsNeeta Dhabhai
 
Exercise and health
Exercise and healthExercise and health
Exercise and healthfathi neana
 
Weight loss vs Exercise in Diabetes (Steno Symposium 2014)
Weight loss vs Exercise in Diabetes (Steno Symposium 2014)Weight loss vs Exercise in Diabetes (Steno Symposium 2014)
Weight loss vs Exercise in Diabetes (Steno Symposium 2014)mtrenell
 

Similar to Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol) (20)

Compounding for Erectile Dysfunction
Compounding for Erectile DysfunctionCompounding for Erectile Dysfunction
Compounding for Erectile Dysfunction
 
GLP1 ANALOGUES- BEYOND DIABETES.pptx
GLP1 ANALOGUES- BEYOND DIABETES.pptxGLP1 ANALOGUES- BEYOND DIABETES.pptx
GLP1 ANALOGUES- BEYOND DIABETES.pptx
 
Pain Management in the Elderly
Pain Management in the ElderlyPain Management in the Elderly
Pain Management in the Elderly
 
Penis ed- management
Penis  ed- managementPenis  ed- management
Penis ed- management
 
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
 
Postprandial hypertriglyceridemia and androgen dysfunction
Postprandial hypertriglyceridemia and androgen dysfunctionPostprandial hypertriglyceridemia and androgen dysfunction
Postprandial hypertriglyceridemia and androgen dysfunction
 
Ndei Beta Cell Slide Kit Clinical Implications
Ndei Beta Cell Slide Kit   Clinical ImplicationsNdei Beta Cell Slide Kit   Clinical Implications
Ndei Beta Cell Slide Kit Clinical Implications
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunction
 
New treatment trends in alzheimer disease
New treatment trends in alzheimer diseaseNew treatment trends in alzheimer disease
New treatment trends in alzheimer disease
 
LHRH agonist vs antagonist in prostate cancer
LHRH agonist vs antagonist in prostate cancerLHRH agonist vs antagonist in prostate cancer
LHRH agonist vs antagonist in prostate cancer
 
pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...
pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...
pdfslide.net_adam-syndrome-androgen-deficiency-in-the-aging-man-andropause-56...
 
ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapy
ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapyECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapy
ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapy
 
Estado actual de terapia sistémica en cáncer renal metastásico
Estado actual de terapia sistémica en cáncer renal metastásicoEstado actual de terapia sistémica en cáncer renal metastásico
Estado actual de terapia sistémica en cáncer renal metastásico
 
Treatment Duration Aderence Compliance and Concordance and Management Of Oste...
Treatment Duration Aderence Compliance and Concordance and Management Of Oste...Treatment Duration Aderence Compliance and Concordance and Management Of Oste...
Treatment Duration Aderence Compliance and Concordance and Management Of Oste...
 
Kiem soat duong huyet tren tien dtd
Kiem soat duong huyet tren tien dtdKiem soat duong huyet tren tien dtd
Kiem soat duong huyet tren tien dtd
 
Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...
Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...
Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated ...
 
Evidence based medical management of aub different options
Evidence based medical management of aub different optionsEvidence based medical management of aub different options
Evidence based medical management of aub different options
 
Exercise and health
Exercise and healthExercise and health
Exercise and health
 
PIIS2211816016302873
PIIS2211816016302873PIIS2211816016302873
PIIS2211816016302873
 
Weight loss vs Exercise in Diabetes (Steno Symposium 2014)
Weight loss vs Exercise in Diabetes (Steno Symposium 2014)Weight loss vs Exercise in Diabetes (Steno Symposium 2014)
Weight loss vs Exercise in Diabetes (Steno Symposium 2014)
 

Recently uploaded

Indian Best Pharmaceutical Company - Solace biotech limited
Indian Best Pharmaceutical Company - Solace biotech limitedIndian Best Pharmaceutical Company - Solace biotech limited
Indian Best Pharmaceutical Company - Solace biotech limitedSBL DIGITAL
 
The Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar Levels
The Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar LevelsThe Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar Levels
The Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar Levelszackyzm02
 
how to look more attractive? | Boys Edition
how to look more attractive? | Boys Editionhow to look more attractive? | Boys Edition
how to look more attractive? | Boys Editionalibieb33d
 
Seminario BioMol- Aura Cristina Peña Santos
Seminario BioMol- Aura Cristina Peña SantosSeminario BioMol- Aura Cristina Peña Santos
Seminario BioMol- Aura Cristina Peña SantosAuraCristinaPeaSanto
 
ROJoson PEP Talk: Cancer Surveillance after Definitive Treatment
ROJoson PEP Talk: Cancer Surveillance after Definitive TreatmentROJoson PEP Talk: Cancer Surveillance after Definitive Treatment
ROJoson PEP Talk: Cancer Surveillance after Definitive TreatmentReynaldo Joson
 
ABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdf
ABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdfABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdf
ABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdfAbdurahmanRafeeq
 
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.Divya Kanojiya
 
Introducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessIntroducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessFredrick Amos
 
Dental Hygiene Library session Searching - 2nd class
Dental Hygiene Library session Searching - 2nd classDental Hygiene Library session Searching - 2nd class
Dental Hygiene Library session Searching - 2nd classHVCClibrary
 
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxGLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxWINCY THIRUMURUGAN
 
Infective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptxInfective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptxShashi Prakash
 
Seminario Biología Molecular, Luisa Maradey
Seminario Biología Molecular, Luisa MaradeySeminario Biología Molecular, Luisa Maradey
Seminario Biología Molecular, Luisa Maradeylmaradeya
 
Feel and Look Years Younger With Nutra IGF 1 Supplement
Feel and Look Years Younger With Nutra IGF 1 SupplementFeel and Look Years Younger With Nutra IGF 1 Supplement
Feel and Look Years Younger With Nutra IGF 1 SupplementWintersBiotechnology
 
Anatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptx
Anatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptxAnatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptx
Anatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptxDr. Prabhat Devkota, MD
 
Target pain receptors with essential oils
Target pain receptors with essential oilsTarget pain receptors with essential oils
Target pain receptors with essential oilsKevin KF Ng
 
The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call
The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up CallThe EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call
The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Callsemualkaira
 
Presentation on heADCAHE AND FACIAL PAIN.pptx
Presentation on heADCAHE AND FACIAL PAIN.pptxPresentation on heADCAHE AND FACIAL PAIN.pptx
Presentation on heADCAHE AND FACIAL PAIN.pptxdruttamnepal
 
pharmacokinetics & pharmacodynamics- seminar- magdum sir.pptx
pharmacokinetics & pharmacodynamics- seminar- magdum sir.pptxpharmacokinetics & pharmacodynamics- seminar- magdum sir.pptx
pharmacokinetics & pharmacodynamics- seminar- magdum sir.pptxsnehapachore2
 

Recently uploaded (20)

Indian Best Pharmaceutical Company - Solace biotech limited
Indian Best Pharmaceutical Company - Solace biotech limitedIndian Best Pharmaceutical Company - Solace biotech limited
Indian Best Pharmaceutical Company - Solace biotech limited
 
The Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar Levels
The Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar LevelsThe Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar Levels
The Natural Method That Supports Healthy Weight Loss & Steady Blood Sugar Levels
 
how to look more attractive? | Boys Edition
how to look more attractive? | Boys Editionhow to look more attractive? | Boys Edition
how to look more attractive? | Boys Edition
 
Seminario BioMol- Aura Cristina Peña Santos
Seminario BioMol- Aura Cristina Peña SantosSeminario BioMol- Aura Cristina Peña Santos
Seminario BioMol- Aura Cristina Peña Santos
 
Radiation and Spectra.pptx
Radiation and Spectra.pptxRadiation and Spectra.pptx
Radiation and Spectra.pptx
 
ROJoson PEP Talk: Cancer Surveillance after Definitive Treatment
ROJoson PEP Talk: Cancer Surveillance after Definitive TreatmentROJoson PEP Talk: Cancer Surveillance after Definitive Treatment
ROJoson PEP Talk: Cancer Surveillance after Definitive Treatment
 
ABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdf
ABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdfABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdf
ABDULRAHMAN AL RAFIQ UPDATED MANAGEMENT OF ACUTE PULMONARY EMBOLISM .pdf
 
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
 
Introducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessIntroducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitness
 
Dental Hygiene Library session Searching - 2nd class
Dental Hygiene Library session Searching - 2nd classDental Hygiene Library session Searching - 2nd class
Dental Hygiene Library session Searching - 2nd class
 
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxGLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
 
Infective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptxInfective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptx
 
KETO DIET
KETO DIETKETO DIET
KETO DIET
 
Seminario Biología Molecular, Luisa Maradey
Seminario Biología Molecular, Luisa MaradeySeminario Biología Molecular, Luisa Maradey
Seminario Biología Molecular, Luisa Maradey
 
Feel and Look Years Younger With Nutra IGF 1 Supplement
Feel and Look Years Younger With Nutra IGF 1 SupplementFeel and Look Years Younger With Nutra IGF 1 Supplement
Feel and Look Years Younger With Nutra IGF 1 Supplement
 
Anatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptx
Anatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptxAnatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptx
Anatomy and Physiology of Optic Nerve Dr.PrabhatDevkota.pptx
 
Target pain receptors with essential oils
Target pain receptors with essential oilsTarget pain receptors with essential oils
Target pain receptors with essential oils
 
The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call
The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up CallThe EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call
The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call
 
Presentation on heADCAHE AND FACIAL PAIN.pptx
Presentation on heADCAHE AND FACIAL PAIN.pptxPresentation on heADCAHE AND FACIAL PAIN.pptx
Presentation on heADCAHE AND FACIAL PAIN.pptx
 
pharmacokinetics & pharmacodynamics- seminar- magdum sir.pptx
pharmacokinetics & pharmacodynamics- seminar- magdum sir.pptxpharmacokinetics & pharmacodynamics- seminar- magdum sir.pptx
pharmacokinetics & pharmacodynamics- seminar- magdum sir.pptx
 

Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) ChM (urol)

  • 1. Dr. Mohand Yaghi PgDip urol (MU) ChM urol (RCSEdin.)
  • 2.  Physiology of erection :
  • 4.  KUW: of 323 patients with DM 2, 31% had ED, IIEF-5 used. (The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int. 2007 Jan;99(1):130-4)  KSA: 376 pts, DM 2, 81% reported ED. (Erectile Dysfunction and Other Sexual Activity Dysfunctions among Saudi Type 2 Diabetic Patients. AlMogbel . Int J Health Sci (Qassim). 2014 Oct;8(4):347-59)  Risk factors – age, smoking, glu control, duration of DM & smoking, occupation, income, education.
  • 9.  beta blockers, diuretics, hydralazine, CCB  Centrally acting: Methyldopa, Clonidine.  Antidepressants: Benzodiazepines, Phenothiazines, Haloperidol, Li, MAOIs, Tricyclics.  Hormones: anti-androgens, LHRH agonists  Others: Cimetidine, Digoxin, Metoclopromide, Statins.
  • 10.  Controversial  Any drugs which lowers BP can cause ED (J. Jensen et al. “The prevalence and etiology of impotence in 101 male hypertensive outpatients,” American Journal of Hypertension, vol. 12, no. 3, pp. 271–275, 1999)  small studies suggested that some antihypertensive drug classes could have less harmful or even beneficial effect on sexual function like CCB (C. A. Derby 2001), angiotensin II receptor blockers (M. Böhm et al. 2007) , and nebivolol (S. Bansal 1998)
  • 11.  96 patients (all males, age 52+/-7 years) with newly diagnosed CVD and not suffering from ED.  Divided to 3 groups: group A didn’t know the drug, Group B knew the drug but not the side effect, Group C knew the drug and the side effects.  Results: ED in Group A 3.1%, group B 15.6%, group C 31.2%/
  • 12.  Endothelial dysfunction, neuropathy, vascular changes.  Penile tissue from diabetic men with ED demonstrates impaired neurogenic and endothelium-mediated relaxation of smooth muscle. (aenz de Tejada I et al. 1989, N Engl J Med 320:1025 –1030, 1989)  Increased accumulation of advanced glycation end products (AGEs),23 and upregulation arginase, a competitor with nitric oxide synthase for its substrate L-arginine. (Seftel AD et al., Urology 50:1016 –1026, 1999)  decreased synthesis, release, or activity of nitric oxide through increased polyol pathway flux, intracellular accumulation of AGEs, activation of protein kinase C, and increased flux through the hexosamine pathway. (Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813 –820, 2001)
  • 13.  Experimental hyperglycemia may also affect cavernosal smooth muscle cell contractile responses.  penile smooth muscle has augmented force responses to vaconstrictors, possibly mediated by changes in expression of protein kinase C (Chitaley K et al., Nat Med7 : 119–122,2001)  Arterial morphology, flow, and diameter differ between diabetic and nondiabetic populations with ED. (Ruzbarsky V et al. Invest Urol 15::194 –199, 1997. Lehman TP et al., J Urol129 : 291– 294,1983)
  • 14. EAU guidelines 2015 • History ( sexual relations, emotional status, duration, rigidity, morning erection), IIEF-5, depression? Hypogonadism? IPSS. • Physical exam.(GU, Vascular, neurology, endocrine). • Lab. (HBA1c, FBG, lipids profile, morning Testosterone, PSA, TFTs). Prolactin & LH if Testosterone is low.
  • 15.  Nocturnal penile tumescence and rigidity test (NPTR)- erection with 60% of rigidity for > 10min. (Rigiscan)  Intra-cavernous injection test- functional test.  Duplex US- PSF > 30cm/s, end-diastolic velocity < 3cm/s.  Internal pudendal Arteriography- rarely performed only perform reconstruction surgery.  Psychiatric assessment- specially in young pts.
  • 20.  Life style changes particularly important in individuals with ED and comorbidities like DM/HT. Increase PDE5Is response. Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000 Aug;56(2):302-6.  Prospective study, 1097 pts, age (40-70), examined life changes in smoking, physical activity, alcohol consumption, obesity.  Results: Only obesity (p 0.006), and physical activity (p 0.01) were associated with ED.
  • 21.  RCT, single blinded, 110 obese pts, age 35- 55.  After 2 yrs, BMI decreased from 36.9 to 31.2 in the interventional arm.  IIEF-5 increased from 13 to 17  17 men reported IIEF score of 22 or higher.  Conclusion: 1/3 of the pts reported improvement in sexual activity after weight loss .
  • 22.  Sildenafil (Viagra) : first PDEIs 1998, doses 25, 50, 100 mg.  Initiation dose 50mg, effect starts from 30- 60min., may last for 12 hrs.  In patients with diabetes, 66.6% reported improved erections (GAQ) and 63% successful intercourse attempts compared to 28.6% and 33% of men taking placebo. Stuckey BG, Jadzinsky MN, Murphy LJ, et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 2003 Feb;26(2):279-84.
  • 23.  Effect after 30min, peak after 2 hours, maintained eff. Up to 36 hrs. absorption not affected by fatty food like Viagra/Levitra.  10, 20mg approved. Initial dose 10mg.  Diabetics- 64% reported improved erections versus 25% of patients in the control group.  But diabetic pts remain poor responders to ON DEMAND Tadalafil (45% for 10mg and 50% for 20mg) Fonseca V, Seftel A, Denne J, et al. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004 Nov;47(11):1914-23.
  • 24.  Starts 30min., 5mg, 10mg, 20mg approved from “on-demand”.  diabetic patients remain poor responders to on-demand with a successful intercourse rates increasing from 23% with placebo to 49% and 54% with 10 and 20 mg of Vardenafil on-demand.
  • 25.  Highly selective PDE5Is, fast ( 15-30min), lasts for > 6hrs, half-life 6-17hrs.  Side effects is lower than other PDE5.  Recommended dose 100mg (15-30min before intercourse).  Success rates: 41.3%, 57.1%, and 57.0% for avanafil 50 mg, 100 mg, and 200 mg respectively in the general population with ED. (Goldstein et al. 2012b).  34.4% and 40.0% for 100 mg and 200 mg in men with diabetes (89.5% type 2). Goldestein et al. 2012b
  • 26.  Daily tadalafil led to a significantly higher IIEF score and higher completion of successful intercourse attempts compared to on-demand tadalafil. McMahon C. Comparison of efficacy, safety and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J Sex Med 2005 May;2(3):415-25.  Alternative to on-demand dosing of tadalafil for couples who prefer spontaneous rather than scheduled sexual activities  Double-blind, placebo-controlled study of 298 men with diabetes and ED, 2.5 and 5 mg tadalafil once daily for 12 weeks was efficacious and well tolerated. Hatzichristou D, Gambla M, Rubio-Aurioles E, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med 2008 Feb;25(2):138-46.
  • 27.  Between 70-90% of patients choose Tadalafil (Cialis). 1. von Keitz A, Rajfer J, Segal S et al. A multicenter, randomized, double-blind, crossover study to evaluate patient preference for tadalafil and sildenafil. Eur Urol 2004; 45: 499- 507. 2. Stroberg P, Murphy A, Costigan T. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference. Clin Ther 2003; 25: 2724-37. 3. Eardley I, Mirone V, Montorsi F et al. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men nave to phosphodiesterase 5 inhibitor therapy. BJU Int2005; 96: 1323-32.
  • 28.  Doesn’t increase MI, or time to ischemia in pts with stable angina. In fact, there is evidence that PDE5Is improve exercise test.  Nitrates contraindicated  If patient on PDE5Is develops angina, Nitroglycerine should be given 24hrs (Viagra)/48hrs (Cialis)  α-Blockers + PDE5Is (Viagra) = orthostatic hypotension (first 4 hrs)  patients should be stable on α-blocker therapy prior to initiating combined treatment, and that the lowest dose should be started initially of PDE5Is
  • 30.  Empty stomach, no alcohol, no fatty food, sexual stimulation, appropriate time for absorption (AT LEAST 60min required for men using Sildenafil and Vardenafil, and up to 2 h being required for men using tadalafil), adequate dose.
  • 31.  Alprostadil (Caverject)- PGE1  most efficacious as monotherapy at a dose of 5-40 μg, starts 5-15min.  Efficacy rates for intracavernous alprostadil of > 70% in general ED populations, as well as CVD, DM.  sexual activity after 94% of the injections and satisfaction rates of 87-93.5% in patients and 86-90.3% in partners.
  • 32.  Penile pain (50%), prolonged erections (5%), priapism (1%), fibrosis (2%), hypotension.  Pain can be alleviated with the addition of sodium bicarbonate or local anaesthesia.  Cavernosal fibrosis clears within a few months after temporary discontinuation of the injection.  Contraindications: bleeding disorders, risk of priapism.  Drop-out rates of 41-68%, with most dropouts occurring within the first 2-3 months.
  • 33.  MUSE- Erections sufficient for intercourse are achieved in 30-65.9%, constricting ring increase the response  local pain (29-41%) and dizziness with possible hypotension (1.9-14%). Penile fibrosis and priapism(< 1%), urethral bleeding (5%) and urinary tract infections (0.2%).  alternative to intracavernous injections in patients who prefer a less-invasive and less effective treatment.
  • 37.  Penile Prosthesis – inflatable, malleable devices.  For non-responders to oral therapy or who prefer a permanent solution.  Peno-scrotal approach or infrapubic approach.  Highest satisfaction rates (92-100% in patients and 91-95% in partners).  Complications: mechanical failure (>5% after 5yrs), infection (2-3%), diabetics have the same incidents.
  • 39.  ED evaluation is crucial in patients over 40.  ED is treatable condition.  Life style changes make some difference.  Doctor-patient relationship and communication is essential.  Variety of ED treatments exists.